Strength and lean body mass gains
A 12-week double-blind RCT in resistance-trained men demonstrated PEAK ATP® (400 mg/day) combined with resistance training significantly increased muscle thickness, lean body mass, and total body strength vs. placebo + training. A meta-analysis of 5 RCTs confirmed significant improvements in maximal strength with ATP supplementation vs. placebo, particularly in resistance-trained men.
Fatigue resistance and endurance maintenance
Acute PEAK ATP® supplementation (400 mg) significantly improved maintenance of peak force output during repeated high-intensity sets — reducing fatigue rate and preserving peak torque in later sets of exhaustive exercise. This anti-fatigue mechanism is distinct from energy production support (creatine) and works through improved blood flow and reduced muscle fatigue signaling.
Blood flow and muscle vasodilation
Extracellular ATP activates P2Y purinergic receptors on endothelial cells, triggering nitric oxide and prostaglandin release that drives vasodilation in active muscle. This blood flow enhancement improves oxygen and nutrient delivery to working muscle — complementary to NO-boosting ingredients like L-citrulline but through a completely different mechanism.
Amino acid absorption enhancement
New 2025 research confirms oral PEAK ATP® significantly enhances amino acid bioavailability following protein consumption in both younger and older adults. ATP's role in intestinal amino acid transport (stimulating P2Y receptors on enterocytes to enhance amino acid uptake) creates a novel application as a protein-potentiating ingredient in protein powders and recovery formulas.
Extracellular purinergic receptor signaling
Orally consumed ATP is not primarily absorbed intact into circulation — instead, it acts as an extracellular signaling molecule in the gut and vasculature by activating P2X and P2Y purinergic receptors on intestinal epithelium, endothelial cells, and red blood cells. P2Y receptor activation triggers NO-mediated vasodilation, P2X activation enhances muscle calcium release for stronger contractions, and intestinal P2Y signaling enhances amino acid transporter activity. This extracellular signaling mechanism explains ATP's efficacy despite limited systemic absorption.
Randomized, double-blind, placebo-controlled trial of PEAK ATP® (400 mg/day) + resistance training vs. placebo + training in resistance-trained men for 12 weeks. Published in Journal of the International Society of Sports Nutrition.
Resistance-trained men. 12-week training + supplementation RCT.
PEAK ATP® significantly increased muscle thickness (+1.7 cm quad), lean body mass (+1.7 kg), vertical jump power (+30%), and total body strength vs. placebo group. Blood flow and muscle excitability markers improved. No adverse effects at 400 mg/day for 12 weeks.
Systematic review and meta-analysis of 5 human clinical studies (2000–2022) examining oral ATP supplementation effects on maximal strength.
5 RCTs, resistance-trained and recreationally active adults.
ATP supplementation produced significant improvements in maximal strength vs. placebo across all 5 studies. Effect concentrated in resistance-trained men. 400 mg/day for up to 12 weeks deemed safe. Supports PEAK ATP® as evidence-based strength and performance ingredient.